LENDER-PG24I10805EB000192
$495.00
Purchase for full contact information of one or more deal team members. All purchases are final and non-refundable.
Description
– Alternative_Lender
– Loans against cash flow, assets or growth stories
– Primarily lends to companies in North America, Australia, New Zealand, and South America
– 85% of loans are for technology-related companies, with a focus on life sciences such as medical device and healthcare IT
– Target companies with revenue of $10 million or more
– Underwrite loans based on growth potential and future cash flow, not necessarily requiring positive EBITDA
– Will consider loans for publicly traded companies
– Approximately 50% of deals are conducted outside of the United States